Printer Friendly

Randomised controlled trial: Effects of aerobic exercise training programme on indices of adiposity and metabolic markers in hypertension.

Byline: Sikiru Lamina, Chuba Goddy Okoye and Shmaila Mustapha Hanif

Abstract

Objective: To investigate the effects of interval training programme on blood pressure, maximal oxygen consumption, indices of adiposity and metabolic markers in black African men with essential hypertension.

Methods: The study was conducted at Murtala Muhammed Specialist Hospital, Kano, Nigeria, from October 24, 2007 to February 24, 2009. It comprised 245 male patients with mild to moderate (systolic blood pressure 140-179 and diastolic blood pressure 90-109 mmHg) essential hypertension who were age-matched and grouped into experimental and control groups. The experimental group was involved in an 8-week training programme of between 45 and 60 minutes, while the controls remained sedentary during the period. Cardiovascular parameters, maximal oxygen consumption, per cent body fat, waist-to-hip ratio, body mass index, fasting blood sugar, total cholesterol, triglyceride, high density lipoprotein, low density lipoprotein and artherogenic index were assessed. Analysis of co-variance and Pearson correlation tests were used in data analysis which was done using SPSS 16.

Results: The study had 140 (57.1%) cases with a mean age of 58.90+-7.35 years, and 105 (42.9%) controls with a mean age of 58.27+-6.24 years. It revealed significant increased effect of interval training programme on maximal oxygen consumption and high-density lipoprotein. There was significant reduction in on all the other controls. Changes in maximal oxygen consumption as a result of interval training significantly and negatively correlated with the other variables except high-density lipoprotein.

Conclusions: The therapeutic role of interval exercise training on blood pressure reduction may be mediated through elevation of high-density lipoprotein, reduction of other markers of metabolism, and reduction in bodyweight and fatness.

Keywords: Hypertension, Adiposity, Metabolic markers, Lipid profile, Artherogenic, Exercise. (JPMA 63: 680; 2013).

Introduction

Hypertension and Hypercholesterolaemia contribute to endothelial dysfunction accompanied by inflammation in the vessel wall, increased lipoprotein oxidation, smooth muscle cell proliferation, extracellular matrix deposition, accumulation of lipid-rich material, activation of platelets, and thrombus formation; these pathogenic features contribute to the development of atherosclerosis and coronary heart disease (CHD).1

Hypertension has become one of the most powerful predictors of CHD and the risk increases markedly when high blood pressure is accompanied with other risk factors. High levels of high-density lipoprotein (HDL) may have a protective role against coronary atherosclerosis.2 About 40% of hypertensive patients also have high blood cholesterol levels and factors that increase risk for coronary events in hypertensive individuals which include; elevated low-density lipoprotein (LDL) or total cholesterol (TC), smoking, impaired glucose tolerance (IGT) and reduced HDL.3

Most of the previous studies investigating the effects of exercise on older hypertensive population have been conducted using white, Caucasian and other mixed black subjects. However, studies have implicated genetics, heredity, race, ethnicity, environmental factors and gene-environmental interaction in the aetiology and biomarkers of inflammation in hypertension.4 Furthermore, Bouchard et al reported that genetics plays a major role in a person's maximal oxygen consumption (VO2max), and that heredity can account for up to 25-50% of the variance seen between individuals.5 This interpersonal and inter-racial difference clearly indicates the needs for study on pure black African population. It was for this very purpose that the current study was conducted.

Subjects and Methods

The age-matched randomised independent-control group (pretest-post-test) study was conducted on male essential hypertensive subjects attending the Hypertensive Clinic of Murtala Muhammed Specialist Hospital, Kano, Nigeria, between October 24, 2007 and February 24, 2009. Sample size was determined using the sample size calculator by Creative Research System Survey Software (CRSSS) (Petaluma, CA, USA).6 The subjects were fully informed about the experimental procedures, risk and protocol, and informed consent was obtained from each of them in accordance with the American College of Sports Medicine (ACSM)7 guidelines. Only those who volunteered to participate in the study were recruited. Subjects between the age range of 45 and 70 years with chronic mild to moderate and stable (> 1 year duration) hypertension (systolic blood pressure [SBP] between 140-179 and diastolic blood pressure [DBP] between 90-109 mmHg) were selected.

Only those who had stopped taking anti-hypertensive drugs or were on a single anti-hypertensive medication (monotherapy) were recruited.8 They were sedentary and had no history of psychiatry or psychological disorders or abnormalities.

Obese or underweight (body mass index [BMI] between 20 and 30 kg/m2), smokers, alcoholics, diabetics, other cardiac, renal, respiratory disease patients were excluded. Those involved in vigorous physical activities

and above-average physical fitness (VO2max >27 and >33ml/kg.min for over 60 & 50 years old respectively) were also excluded.

A total of 324 chronic and stable, essential mild to moderate male hypertensive patients satisfied the necessary study criteria. The subjects were age-matched and randomly grouped into cases (162) and controls (162) groups. Ethical approval was granted by the Ethical Committee/Board of Kano State Hospitals Management Board.

Initially, all subjects on anti-hypertensive drugs were asked to stop all forms of medication and were given placebo tablets consisting of mainly lactose and inert substance, in a double-blind method. All subjects including those not on any anti-hypertensive medications, were placed on placebo tablets for during the 'wash out' phase which lasted 7 days. The purpose of the period was to get rid of the effects of previously taken anti-hypertensive drugs/medications. During the period all subjects were instructed to report to the hypertensive clinic for daily blood pressure monitoring and general observation. The pre-test procedure was conducted on the last day of the 'wash out' period at the Department of Physiotherapy of the hospital.

Subjects resting SBP and DBP were monitored from the right arm as described in literature,9 using an automated digital electronic BP monitor (Omron digital BP monitor, Medel 11 EM 403c; Tokyo Japan). These measurements were monitored between 8am and 10am on each test day.

Both pre- and post-treatment venous blood samples were obtained between 8am and 10pm after about 12-hour overnight fast (fasting blood sample). A 5ml syringe was used for blood sample collection.9 One milliliter from the blood sample was immediately transferred to a special container containing anti-coagulant (heparin, 75U/ml) for white blood cell (WBC) count. The remaining 4ml blood samples were allowed to coagulate (clot) at room temperature for one hour and centrifuged for serum. Serum samples were transferred to plastic containers (vials), sealed, labelled and stored in a refrigerator at -80degC until analysis.

Fasting blood sugar (FBS) was determined using commercial enzymatic method (Randox kits and manuals by Randox Laboratory, Antrim, United Kingdom).

Serum lipid analysis for TC, TG and HDL were determined using commercial enzymatic method (Randox kits and manuals by Randox Laboratory, Antrim, United Kingdom). LDL was estimated indirectly using the formula: Adults LDL = TC- (TG/5)-HDL.10

Artherogenic index was estimated from the ratio of TC and HDL (TC/HDL).9

The Young Men Christian Association (YMCA) submaximal cycle ergometry test protocol was used to assess subject's aerobic power.7 The protocol uses two to four 3-minute stages of continuous exercise, needing two heart rate (HR) output data points (steady state HR) of between 110 and 150 beats/min. The two steady-state HR were plotted against the respective workload on the YMCA graph sheet. A straight line was drawn through the two points and extended to the subjects' predicted maximum HR (220-Age). The point at which the diagonal line intersects the horizontal predicted HR max line represents the maximal working capacity for the subject. A perpendicular line was dropped from this point to the baseline where the maximal physical workload capacity was read in kg.m.min-1, which was used to predict the subjects VO2max. This procedure was done for both pre- and post-test stress test.

Following the stress test and prior to the exercise training, all subjects in both the groups were re-assessed by physicians and were prescribed with methyldopa (500mg-1g daily 2-4 in divided doses) based on the subjects' responses and tolerance to therapy. Methyldopa was preferred because it does not alter normal haemodynamic responses to exercise,10 and it is a well-tolerated antihypertensive drug in Africa.11,12 In addition, it is the drug prescribed the most in Kano, where the study was conducted and had proved useful in the treatment of mild to moderately severe hypertension either as monontherapy or combination therapy.12 Subjects maintained these prescriptions with regular medical consultation and observation throughout the 8-week period of exercise training.

The cases exercised on a bicycle ergometer at a low intensity of between 60-79% of their HR max reserve that was estimated from 220 minus the age of a subject. The starting workload was 100kgm (17 watts) which was increased at a pedal speed of 50rpm. The HR max reserve of 60% increased in the first two weeks to level up at 79% HR max reserve throughout the remaining part of the training period at a work/rest ratio of 1:1 of 6 minutes each. The initial duration of exercise session was increased from 45 minutes up at 60 minutes throughout the remaining part of the training. Exercise sessions three times per week was maintained throughout the study period of training for the cases.

The controls were instructed not to undertake any vigorous physical activity during the study period.

At the end of the 8-week training period, all subjects were asked to stop methyldopa and they were prescribed with placebo tablets in a single-blinded method for one week in order to get rid of the effect of methyldopa taken during the training period.

Immediately after the post-training 'wash out' period, fasting blood samples were collected.

Post-training SBP, DBP, C-reactive protein (CRP), WBC, FBS, TC, TG, HDL, LDL, and artherogenic index (AI) assessment and stress test were conducted as earlier described in the pre-test procedures. All pre and post test measurements were recorded on a data sheet.

Following data collection, the measured and derived variables were statistically analysed. The descriptive statistics (Means +- standard deviations) of the subjects' physical characteristics, estimated VO2max, BP, per cent body fat (%BF), BMI, waist-to-hip ratio (WHR), FBS and lipid profile were determined. Analysis of co-variance (ANCOVA) was used to assess the outcome variables. In ANCOVA, the post-test values were the outcome variables and the co-variates were the age and pre-test (baseline) values. Pearson product moment correlation tests were computed for the variables of interest. In the correlation tests, the difference between subjects post-training and pre-training measurements (changed score) were used as dependent measures. The score changed was the difference between the post-test and pre-test values. All statistical analysis was performed on a Toshiba compatible microcomputer using SPSS 16.0. The probability level for all the above tests was set at 0.05 to indicate significance.

Results

Of the total, 245 (75.61%) subjects (140 [57.1%] from the cases, and 105 [42.9%] from the controls) completed the 8-week training programme, while 79 (24.38%) subjects (22 [27.8%] from cases, and 57 [72.2]) from controls) dropped out because of non-compliance, unfavourable responses to methyldopa and exercise training or incomplete data. The data of 245 subjects, as such, was used in the statistical analysis (Figure-1).

Table-1: Groups mean (x) and standard deviation (SD) for pre- and post-test values (n= 245).

Variables###Interval group x+-SD###Control group x+-SD

###Pre-test###Post-test###Pre-test###Post-test

SBP (mmHg)###166.05+-14.10###150.00+-16.67###160.87+-13.23###163.47+-14.88

DBP (mmHg)###96.80+-3.38###94.98+-5.04###97.17+-1.43###96.10+-2.67

VO2max (ml/kg/min)###23.62+-9.15###37.46+-7.42###21.23+-5.76###22.82+-7.44

BMI (kg/m2)###24.96+-3.88###29.26+-4.11###24.16+-4.91###23.30+-5.01

BF (%)###17.69+-6.50###18.78+-6.62###22.27+-9.82###22.25+-9.82

WHR (m)###0.97+-0.07###0.92+-0.14###0.89+-0.18###0.93+-0.07

FBS (mg/dl)###78.64+-23.41###46.82+-11.58###85.27+-21.49###85.33+-22.10

TC (mg/dl)###162.00+-49.31###134.10+-43.91###163.20+-36.61###169.40+-35.47

TG (mg/dl)###109.90+-30.99###96.95+-31.08###102.00+-20.41###113.07+-19.14

HDL (mg/dl)###24.60+-8.51###33.81+-6.38###29.53+-6.55###29.54+-6.57

LDL (mg/dl)###107.45+-41.52###87.11+-37.86###121.73+-33.35###125.40+-33.05

AI (mg/dl)###7.27+-3.31+-3.31###4.16+-1.77###5.62+-1.10###5.84+-1.06

SBP: Systolic blood pressure. DBP: Diastolic blood pressure. VO2 max: Maximal oxygen consumption. BMI: Body mass index. BF: Body fat. WHR: Waist-to-hip ratio. FBS: Fasting blood sugar. TC: Total cholesterol. TG: Triglyceride. HDL: High-density lipoprotein. LDL: Low-density lipoprotein. AI: Artherogenic index.

Table-2: Changed score values and ANOVA test (n= 245).

###Groups changed score values###ANOVA results

Interval group###Control group###

Variables###x+-SD###F-values###p-value

SBP###-16.40+-13.16###2.61+-7.85###137.220###0.000*

DBP###-4.01+-4.34###-1.07+-0.17###42.059###0.000*

VO2max###13.85+-9.94###1.59+-3.54###199.262###0.000*

BMI###-0.70+-0.82###0.14+-0.40###92.991###0.000*

%BF###-9.91+-4.75###-0.02+-0.07###10.006###0.002*

WHR###-0.08+-0.16###0.02+-0.13###24.909###0.000*

FBS###-30.08+-18.72###0.14+-0.40###511.463###0.000*

TC###-22.71+-28.59###6.20+-7.94###160.104###0.000*

TG###-11.69+-7.58###0.07+-8.72###532.172###0.000*

HDL###8.70+-12.15###0.01+-0.33###28.181###0.000*

LDL###-19.80+-12.15###3.67+-3.42###171.679###0.000*

AI###-3.11+-3.61###0.22+-0.30###58.065###0.000*

Significant p less then 0.05.

SBP: Systolic blood pressure. DBP: Diastolic blood pressure. VO2 max: Maximal oxygen consumption. BMI: Body mass index. BF: Body fat. WHR: Waist-to-hip ratio. FBS: Fasting blood sugar. TC: Total cholesterol. TG: Triglyceride. HDL: High-density lipoprotein. LDL: Low-density lipoprotein. AI: Artherogenic index.

The subject's age ranged between 45 and 70 years. The mean age, height, weight, BMI and %BF among the cases were: 58.40+-6.91 years; 167.78+-7.81cm; 70.18+-11.37kg; 24.96+-3.88kg.m-2; and 17.69+-6.50%). Among the controls they were: 58.27+-6.24 years; 167.89+-5.31cm; 68.47+-17.07kg; 24.16+-4.91kg.m-2; and 22.27+-9.82%. There was no significant difference in age between the two groups (t=0.156, p<0.876).

Pre-test versus post-test mean values for various parameters were compared (Table-1).

ANOVA test results indicated a significant reduction in the cases against the controls in SBP, DBP, %BF, BMI, WHR, FBS; TC, TG, HDL, LDL, AI and VO2max (Table-2).

Results indicated significant correlation between baseline VO2max and other variables such as: SBP (r= 0.143); DBP (r= 0.133); %BF (r= 0.128); TC (r= 0.228); TG (r= 0.157); HDL (r= 0.162); LDL (r= 0.322) and AI (r= 0.477). Training changes in VO2max significantly correlated with training changes in other parameters such as: SBP (r= -0.268); DBP (r= -0.237); %BF (r= -0.212); BMI (r= -0.247); WHR (r= -0.247); FBS(r= -0.170); TC (r= -211); TG (r= -0.297); HDL (r= 0.190); LDL (r= -0.173) and AI (r= -0.258). Training changes in AI significantly correlated with training changes in other parameters such as: VO2max, SBP, DBP, %BF, FBS, TC, TG, HDL and LDL at p< 0.05 and p< 0.01 (Figure-2).

Discussion

To our knowledge, this is the first randomised, controlled trial examining the simultaneous impact of interval, moderate intensity, aerobic training on blood pressure, biomarkers of inflammation and metabolic markers in hypertension, particularly among pure black African subjects. However, the purpose of this study was to investigate the effects of interval training on VO2max, BP (SBP & DBP), FBS, indices of cholesterol metabolism (TC, TG, HDL, LDL and AI) and indices of adiposity (%BF, BMI and WHR). Results indicated significant correlation between baseline VO2max and other variables (SBP, DBP FBS, TC, TG, HDL, LDL and AI). There were significant effects of interval training on VO2max, SBP, DBP FBS, BMI, WHR, TC, TG, HDL, LDL and AI. Training changes in VO2max significantly correlated with change in SBP, DBP FBS, BMI, WHR, TC, TG, HDL, LDL and AI. Also, training changes in AI significantly correlated with change in VO2max, SBP, DBP FBS, TC, TG, HDL, LDL and AI.

On VO2max, result of the present study was in agreement with several others. The finding was consistent with a study which looked into the effect of aerobic exercise in patients with essential hypertension.14 Twenty stage 1 and 2 hypertensives participated in a 12-week endurance ergometer at 50% VO2max, 3 to 5 times per week for 30 minutes. They reported significant increase in VO2max at p<0.05. Another study was done on the effect of physical training on maximum aerobic capacity;15 31 (63+-1 years), hypertensive (153+-2/88+-1mmHg) individuals participated in a 6 months aerobic exercise training at 75% VO2max, 3 times weekly for 40 minutes. They reported a significant increase in maximal aerobic capacity (VO2max:18.3+-3.8 versus output of 20.7+-4.2ml/kg/min, at p60 years) hypertensive (SBP >140mmHg and DBP >90mmHg) 54 patients who were randomly assigned to exercise and control groups. The exercise group engaged in a 12-week treadmill exercise programme, while the controls did not.

They reported significant decreased in SBP and DBP by 8.5+-8.2 and 5.1+-3.7mmHg at p25kg/m2 were placed on a low-calorie diet of 800cal/day and engaged in mild exercise. It reported a significant reduction in plasma levels of FBS and insulin at p26kg/m2 were put on a mild hypocaloric diet and exercise on cycle ergometer and walking on treadmill, at an HR corresponding to the anaerobic threshold (AT) for 60 minutes, 3 times per week for a total period of 12 weeks. They were asked to maintain the exercise for one year. The study reported a significant decrease in %BF fat in the hypertensive and normotensive groups following 12 weeks training at p<0.01and during one year follow-up at p<0.0001 in the normotensive group.

A study on apparently healthy adolescents showed that BF seemed to be associated with a higher production of inflammatory proteins.26 Associations between inflammatory proteins, pro-inflammatory cytokines, and adiposity measurements were examined, and it was found that acute-phase inflammatory proteins positively correlated with most measurements of BF.

The current study demonstrated a significant reduction in BMI in the cases over the controls. A study investigated the effect of 6-month aerobic exercise on BP.18 Thirty-five (22 Caucasians; 13 Afro-Americans) sedentary pre-hypertensives and hypertensive subjects. It reported a significant decrease in BMI of both the Caucasians and the Afro-American subjects. Another study also investigated the effect of aerobic exercise on WHR of 14 mild to moderate obese hypertensive subjects.25 It reported a significant decrease in WHR in the hypertensive and normotensive groups following 12 weeks training at p<0.0005 and p<0.001 respectively, and during one year follow-up at p<0.05 in the normotensive group, but not significant in hypertensive group in the one-year follow-up.

Conclusion

The therapeutic role of interval exercise training on BP reduction may be mediated through elevation of HDL; reduction/suppression of artherogenic metabolic markers and reduction in adiposity levels. Also, that interval training programme is an effective adjunct non-pharmacological multi-purpose management of hypertension.

References

1. Vincent MA, Montagnani M, Quon MJ. Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Curr Diab Rep 2003; 3: 279-88.

2. Spate-Douglas T, Keyser RE. Exercise intensity: its effect on high-density lipoprotein profile. Arch Phys Med Rehabil 1999; 80: 691-695.

3. Nieman DC. Exercise testing and prescription: A health-related approach, 5th ed. Boston: McGraw-Hill; 2003.

4. Pendergrass SA, Hayes E, Farina G, Lemaire R, Farber HW, Whitfield ML, et al. Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury. PLoS One 2010; 5: e12106. Published Online First: 17 August 2010. doi: 10.1371/journal.pone.0012106.

5. Bouchard C, Dionne FT, Simoneau JA, Boulay MR. Genetics of aerobic and anaerobic performances. Exerc Sport Sci Rev 1992; 20: 27-58.

6. Creative Research System Survey Software (CRSSS). (Online) (Cited 2012 July 15). Available from URL: http://www.surveysystem.com/ about.htm.

7. American College of Sports Medicine. Position stand. Physical activity, physical fitness, and hypertension. Med Sci Sports Exerc 1993; 25: i-x.

8. Stewart KJ, Bacher AC, Turner KL, Fleg JL, Hees PS, Shapiro EP, et al. Effect of exercise on blood pressure in older persons: a randomized controlled trial. Arch Intern Med 2005; 165: 756-762.

9. Musa DI, Ibrahim DM, Toriola AL. Cardiorespiratory fitness and risk factors of CHD in pre-adolescent Nigerian girls. Journal of Human Movement Studies 2002; 42: 455- 6.

10. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.

11. Mancia G, Ferari L, Gregorini L, Leonett L, Terzoli L, Biachini C, et al. Effects of treatment with methyldopia on basal haemodynamic and on neural control. In: Robertson JS, Pickering GW, Goldwell ADS, eds. The therapeutics of hypertension. London: Royal Society of Medicine and Academic Press Inc. Ltd, 1980; 70-78.

12. Oyewo EA, Ajayi AA, Ladipo GO. A therapeutic audit in the management of hypertension in Nigerians. East Afr Med J 1989; 66: 458-467.

13. Adigun AQ, Ishola DA, Akintomide AO, Ajayi AAL. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. J Hum Hypertens. 2003; 17: 277-285.

14. Mughal M, Alvi IA, Akhund IA, Ansari AK. The effect of aerobic exercise training on resting blood pressure in hypertensive patients. J Pak Med Assoc 2001; 51: 222-6.

15. Dengel DR, Brown MD, Reynolds TH, Kuskowski MA, Supiano MA. Effect of aerobic training on blood pressure sensitivity to dietary sodium in older hypertensives. J Hum Hypertens 2006; 20: 372-8.

16. Smith PJ, Blumenthal JA, Babyak MA, Georgiades A, Hinderliter A, Sherwood A. Effects of exercise and weight loss on depressive symptoms among men and women with hypertensive. J Psychosome Res 2007; 63: 463-9.

17. Westhoff TH, Franke N, Schmidt S, Vallbracht-Israng K, Meissner R, Yildirim H, et al. Too old to benefit from sports? The cardiovascular effects of exercise training in elderly subjects treated for isolated systolic hypertension. Kidney Blood Press Res 2007: 30: 240-7.

18. Blumenthal JA, Sherwood A, Gullette E.C, Babyak M, Waugh R, Georgiades A, et al. Exercise and weight loss reduce blood pressure in men and women with mild hypertension: effects on cardiovascular, metabolic and hemodynamic functioning. Arch Intern Med 2000; 160: 1947-58.

19. Takeshita Y. Changes in insulin sensitivity after weight loss in hypertensive patient with obesity. Nihon Jinzo Gakkai Shi 1995; 37: 384-90.

20. Tsai JC, Chang WY, Kao CC, Lu MS, Chen YJ, Chan P. Beneficial effect on blood pressure and lipid profile by programmed exercise training in Taiwanese patients with mild hypertension. Clin Exp Hypertens 2002; 24: 315-24.

21. Sasaki J, Urata H, Tanabe Y, Kinoshita A, Tanaka H, Shindo M, et al. Mild exercise therapy increases serum high density lipoprotein2 cholesterol levels in patients with essential hypertension. Am J Med Sci 1989; 297: 220-3.

22. Durstine JL, Haskell WL. Effect of exercise training on plasma lipids and lipoproteins. Exerc Sport Sci Rev 1994; 22: 477-521.

23. Oranugo JBC, Igbanugo VC, Agbedana FO. The influence of jogging and circuit training programmes on serum lipid levels of college male individuals. J Nigeria Assoc Sport Sci Med 1992; 4: 94-100.

24. Thomas TR, Adeniran SB, Etheridge GL. Effects of different running programs on VO2 max, percent fat, and plasma lipids. Can J Appl Sport Sci 1984; 9: 55-62.

25. Himeno E, Nishino K, Okazaki T, Nanri H, Ikeda M. A weight reduction and weight maintenance program with long-lasting improvement in left ventricular mass and blood pressure. Am J Hypertens 1999; 12:682-690.

26. Warnberg J, Nova E, Moreno LA, Romeo J, Mesana MI, Ruiz JR, et al. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr 2006; 84:505-512.
COPYRIGHT 2013 Asianet-Pakistan
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Journal of Pakistan Medical Association
Date:Jun 30, 2013
Words:4105
Previous Article:Fingertip injuries in paediatric patients - experiences at an emergency centre in Saudi Arabia.
Next Article:Association between chronic low back pain, anxiety and depression in patients at a tertiary care centre.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |